Np mrd loader

Record Information
Version2.0
Created at2024-09-16 04:50:50 UTC
Updated at2024-09-25 11:50:12 UTC
NP-MRD IDNP0341808
Natural Product DOIhttps://doi.org/10.57994/3294
Secondary Accession NumbersNone
Natural Product Identification
Common Nameparaisariamide C
Description It was first documented in 2024 (PMID: 39316846). Based on a literature review a significant number of articles have been published on paraisariamide C (PMID: 39316832) (PMID: 39316797) (PMID: 39316787) (PMID: 39316769).
Structure
Thumb
SynonymsNot Available
Chemical FormulaC40H65N7O7
Average Mass756.0020 Da
Monoisotopic Mass755.49455 Da
IUPAC Name(3S,6S,9S,12S,15R,18R,21R)-9-benzyl-18-[(2S)-butan-2-yl]-1,3,4,10,21-pentamethyl-6-(2-methylpropyl)-12,15-bis(propan-2-yl)-1,4,7,10,13,16,19-heptaazacyclohenicosane-2,5,8,11,14,17,20-heptone
Traditional Name(3S,6S,9S,12S,15R,18R,21R)-9-benzyl-18-[(2S)-butan-2-yl]-12,15-diisopropyl-1,3,4,10,21-pentamethyl-6-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosane-2,5,8,11,14,17,20-heptone
CAS Registry NumberNot Available
SMILES
[H][C@@]1(NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CC=CC=C2)N(C)C(=O)[C@@H](NC(=O)[C@H](NC1=O)C(C)C)C(C)C)[C@@H](C)CC
InChI Identifier
InChI=1S/C40H65N7O7/c1-14-25(8)33-37(51)42-31(23(4)5)36(50)43-32(24(6)7)40(54)47(13)30(21-28-18-16-15-17-19-28)35(49)41-29(20-22(2)3)39(53)46(12)27(10)38(52)45(11)26(9)34(48)44-33/h15-19,22-27,29-33H,14,20-21H2,1-13H3,(H,41,49)(H,42,51)(H,43,50)(H,44,48)/t25-,26+,27-,29-,30-,31+,32-,33+/m0/s1
InChI KeyAJUJLMAOJPMZSJ-XYRMESBGSA-N
Experimental Spectra
Spectrum TypeDescriptionDepositor EmailDepositor OrganizationDepositorDeposition DateView
HSQC NMR[1H, 13C] NMR Spectrum (2D, 800 MHz, CDCl3, experimental)rmtehan@utica.eduUtica University, Oregon State UniversityRichard Tehan2024-09-16View Spectrum
HMBC NMR[1H, 13C] NMR Spectrum (2D, 800 MHz, CDCl3, experimental)rmtehan@utica.eduUtica University, Oregon State UniversityRichard Tehan2024-09-16View Spectrum
COSY NMR[1H, 1H] NMR Spectrum (2D, 800 MHz, CDCl3, experimental)rmtehan@utica.eduUtica University, Oregon State UniversityRichard Tehan2024-09-16View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, CDCl3, experimental)rmtehan@utica.eduUtica University, Oregon State UniversityRichard Tehan2024-09-16View Spectrum
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
cascadensis
      Not Available
Chemical Taxonomy
ClassificationNot classified
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP2.93ChemAxon
pKa (Strongest Acidic)11.85ChemAxon
pKa (Strongest Basic)-2.7ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area177.33 ŲChemAxon
Rotatable Bond Count8ChemAxon
Refractivity205.65 m³·mol⁻¹ChemAxon
Polarizability82.41 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Wu J, Mo H, An Z, Tang Z, Deng X, Zhou H, Gong Y, Zheng C, Zhuo L, Tan S: Discovery of 7-(1-methyl-1H-pyrazol-4-yl)-1,6-naphthyridine derivatives as potent inhibitors of rearranged during transfection (RET) and RET solvent-front mutants for overcoming selpercatinib resistance. Eur J Med Chem. 2024 Sep 19;279:116891. doi: 10.1016/j.ejmech.2024.116891. [PubMed:39316846 ]
  2. Wang Y, Jin Y, Zhong Y, Zhu P, Li J: Synthesis of Iron-Based Prussian Blue Analogues with Ultralong Cycle Performance in a Novel T-Shaped Collision Microreactor. ACS Appl Mater Interfaces. 2024 Sep 24. doi: 10.1021/acsami.4c12929. [PubMed:39316832 ]
  3. Park J, Park S, Kim J, Cho YJ, Lee JS: Ctr9 promotes virulence of Candida albicans by regulating methionine metabolism. Virulence. 2024 Dec;15(1):2405616. doi: 10.1080/21505594.2024.2405616. Epub 2024 Sep 24. [PubMed:39316797 ]
  4. Calaway C, Walls K, Levitt H, Caplan J, Mann B, Martinez K, Gastaldo R, Haq I, Signorile JF: Frequency of Velocity-Based-Training Frequency Impacts Changes in Muscle Morphology, Neuromuscular Performance, and Functional Capability in Persons With Parkinson's Disease. J Strength Cond Res. 2024 Sep 24. doi: 10.1519/JSC.0000000000004951. [PubMed:39316787 ]
  5. Ali LS, Attia YAM, Mourad S, Halawa EM, AbdElghaffar NH, Shokry S, Attia OM, Makram M, Wadan AS, Negm WA, Elekhnawy E: The missing link between cancer stem cells and immunotherapy. Curr Med Res Opin. 2024 Sep 24:1-35. doi: 10.1080/03007995.2024.2407963. [PubMed:39316769 ]